AN2 Therapeutics, Inc. — SC 13G/A Filings
13 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 13 SC 13G/A documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-002722 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-118948 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-257248 | Nov 13, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-015449 | Aug 28, 2024 | — |
| SC 13G/A | — | 0001373604-24-000073 | Aug 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-089067 | Aug 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023990 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023929 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-030111 | Feb 9, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-029181 | Feb 9, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021812 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000525 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-020803 | Feb 14, 2023 | — |